Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
with the recent publication from Taurx on April 20, there should be decision by UK MHRA in the coming end May meeting. By right, they won't need to review these for another 3-4 months as it's already a 3rd review. first review from July-Dec 24, then June to Sept 25. Now from April 20 - ??.
Maybank Investment cut its target price to RM2.82, after slashing its earnings forecast but kept its “buy” call on the stock. “We believe these headwinds could be temporary,” the research house said.
